Recurrent Angiosarcoma

Known as: Recurrent Hemangiosarcoma, Relapsed Angiosarcoma, Relapsed Hemangiosarcoma 
The reemergence of angiosarcoma after a period of remission.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2018
01219882018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Angiosarcomas are rare malignant tumors of vascular origin that represent a genuine therapeutic challenge. Recently… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
the first case of JDM-associated panniculitis. DM-related panniculitis consists of a mostly lobular panniculitis occurring… (More)
  • figure 2
  • figure 1
  • figure 2
  • figure 1
Is this relevant?
2014
2014
Angiosarcoma is a highly malignant vascular tumor of endothelial origin. Initially, a cutaneous manifestation presents as a… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
A previously healthy 23-year-old woman was admitted to our emergency department (Vall d’Hebron University Hospital, Barcelona… (More)
  • figure 1
  • figure 2
Is this relevant?
2009
2009
Angiosarcoma of the thyroid is a rare and aggressive primary malignant tumor of the thyroid originally reported in patients from… (More)
Is this relevant?
2008
2008
Angiosarcoma of the brain, either primary or metastatic is extremely rare. Moreover, angiosarcoma metastasizing to the brain is… (More)
Is this relevant?
2004
2004
We report a case of recurrent angiosarcoma (AS) in a 63-year-old man, effectively treated with a superselective continuous intra… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
1999
1999
A 77-year-old male patient presented with a 2-year history of recurrent angiosarcoma (AS) of the face and scalp. At the time of… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
1988
1988
The present study represents the first attempt of treating primary angiosarcoma of the breast with adjuvant vinblastine sulfate… (More)
Is this relevant?